Abstract
Gout is a metabolic disorder caused by hyperuricemia resulting in joints and other tissues deposition of urate crystals. Clinical manifestation includes recurrent attacks of arthritis and accumulation of crystalline deposits called tophi. Gout is considered a progressive disease that, without long-term treatment, can progress to severe tophaceous gout. The disease is increasing in prevalence as a result of changes in diet, lifestyle and environmental factors. Hyperuricemia has a fundamental role as risk factor in the development of gout and seems also to be a risk factor for some comorbidities. The goal of the treatment of gout is to reduce serum uric acid levels sufficiently that crystals can no longer form. A future research agenda should include the identification of genes associated with risk for gout and the development of new urate lowering drugs with a specific target. In the next future, controlled studies are also required to understand the significance and the underlying mechanism of the association between hyperuricemia and some comorbidities.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
